Allergen-specific immunotherapy in atopic dermatitis

@inproceedings{Jutel2011AllergenspecificII,
  title={Allergen-specific immunotherapy in atopic dermatitis},
  author={Marek Jutel and Katarzyna Solarewicz-Madejek and Agnieszka Węgrzyn},
  year={2011}
}
Allergen-specific immunotherapy (SIT) is the only known causal allergy treatment. Although used for over 100 years, its mechanisms are still the subject of investigation. The safety and efficacy of SIT have been demonstrated in children and adults in many clinical trials, which showed the essential role of SIT in prevention of both new allergy diseases (especially asthma) and new sensitizations. This method is currently recommended in the treatment of IgE-mediated aeroallergens and hymenoptera… CONTINUE READING

From This Paper

Topics from this paper.
2 Citations
61 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 61 references

Efficacy and safety of a depigmented polymerised mite extract in patients suffering from atopic eczema with clinical relevant IgE-mediated sensitisation against house dust mites

  • N Novak, T Zuberbier, A. Sager
  • Allergy
  • 2011
Highly Influential
20 Excerpts

Similar Papers

Loading similar papers…